Cas 1313034-99-9,N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide

1313034-99-9

Post Buying Request

Basic information

Product Name: N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide
Synonyms: N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide
CAS NO:1313034-99-9
Molecular Formula:
Molecular Weight: 405.42
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide(CAS DataBase Reference)
NIST Chemistry Reference: N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide(1313034-99-9)
EPA Substance Registry System: N-phenyl-4-[7-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-4-yl]piperazine-1-carboxamide(1313034-99-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1313034-99-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1313034-99-9 Suppliers

Recommended suppliers

1313034-99-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1313034-99-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,3,0,3 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1313034-99:
(9*1)+(8*3)+(7*1)+(6*3)+(5*0)+(4*3)+(3*4)+(2*9)+(1*9)=109
109 % 10 = 9
So 1313034-99-9 is a valid CAS Registry Number.

1313034-99-9Upstream product

1313034-99-9Downstream Products

1313034-99-9Relevant academic research and scientific papers

NOVEL ARYL UREA DERIVATIVE

-

, (2012/11/13)

There is a need for FAAH inhibitors capable of oral administration and having excellent efficacy, particularly agents for the prevention and treatment of pain. Disclosed are novel arylurea compounds represented by formula (I), salts or solvates thereof, and pharmaceutical compositions comprising the same as an active ingredient. The pharmaceutical composition is used primarily for FAAH inhibitors, or agents for prevention and treatment of pain.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1313034-99-9